here - FIP

More documents

Recommendations

Info

28 Jackie Parkin (Vice-President Immuno-Inflammation Therapy Area Unit, GSK, UK) Jonathan Peck (Institute for Alternative Futures, USA) Lloyd Sansom (Special Advisor on National Medicines Policy Framework, Australia) Per Troein (VP Strategic Partners IMS Health, UK) Jack Watters (Vice-President External Medical Affairs, Pfizer, USA) Kris Weerasuriya (World Health Organization, Switzerland) Durhane Wong-Rieger (Chair, International Alliance of Patients’ Organizations (IAPO), Canada) Moderators: Douwe Breimer (University of Leiden, the Netherlands) John Chave (General Secretary, Pharmaceutical Group of the European Union (PGEU), Belgium) Daan Crommelin (FIP/ Utrecht University, the Netherlands) Tom Menighan (CEO, American Pharmacists Association (APhA), USA) Ema Paulino (FIP, Portugal) Rapporteurs to the Ministers Summit: Harvey Fineberg (President, Institute of Medicine, USA) Xuanhao Chan, Diane Gal, and Tana Wuliji (FIP) FIP representatives: Luc Besançon (FIP Acting General Secretary for Professional, Scientific and External Affairs, the Netherlands) Michel Buchmann (FIP President, Switzerland) Andy Gray (FIP Board of Pharmaceutical Practice Chairman, South Africa) Henk de Jong (FIP Scientific Secretary, the Netherlands) Prafull Sheth (FIP Vice-President, India) Guest Contributors: Rosemary Bryant (President, International Council of Nurses (ICN), Switzerland) Carissa Etienne (Assistant Director General, WHO, Switzerland) Susanne Keitel (EDQM, Council of Europe, France) Gerben Klein Nulent (GIRP) Otmar Kloiber (CEO, World Medical Association (WMA), France) Bernard Mauritz (World Self Medication Industry (WSMI)) Additional Programme Advisors: Emma Andrews (Pfizer, USA) Andrew Bonser (Alliance Boots, UK) Jan Smits (KNMP, the Netherlands) Pieter Stolk (Utrecht University, the Netherlands)
Session Participants: The Session participants included FIP Elected Officials, Representatives from National and Regional FIP Member Organisations as well as Representatives from Ministries of Health. Overall, over 200 participants from 44 countries contributed to this event. Thank you to the World Health Organization and to IMS Health for the valuable contributions made to the debate through the preparation and presentation of the two technical reports. Report Editor: Diane Gal Design and layout: Jackson Chang (www.jacksonchang.nl) Photographs: Matthias Sigmund 29
Page 1: Report on the FIP Stakeholder Round
Page 4 and 5: 4 contentS • Foreword • Executi
Page 6 and 7: 6 executIve SummaRy Harvey Fineberg
Page 8 and 9: 8 the patient community, the profes
Page 10 and 11: 10 1. The gathering and use of heal
Page 12 and 13: 12 Scott F. Giberson (Chief Pharmac
Page 14 and 15: 14 even for high income countries.
Page 16 and 17: 16 Durhane Wong-Rieger (Chair, Inte
Page 18 and 19: 18 Ministers of Finance need to be
Page 20 and 21: 20 Andrew Kress (Senior Vice-Presid
Page 22 and 23: 22 call being made for an internati
Page 24 and 25: 24 Michel Dutrée (European Federat
Page 26 and 27: 26 available and accessible to pati
Page 30: 30 FuRtheR InFoRmatIon The Stakehol

here - FIP

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?